Dr. Lara Shirikjian, MD
Claim this profileCollaborative Neuroscience Research, LLC
Studies Bipolar Depression
Studies Depression
2 reported clinical trials
4 drugs studied
Affiliated Hospitals
Clinical Trials Lara Shirikjian, MD is currently running
Investigational Drug
for Bipolar Depression
This trial is testing a new medication called SEP-4199 CR to see if it can help adults aged 18-65 who have depression from Bipolar I disorder. The study will compare the effects of the medication to see if it reduces symptoms of depression. SEP-4199 has shown antidepressant efficacy in a previous study for bipolar depression.
Recruiting1 award Phase 35 criteria
SEP-363856
for Generalized Anxiety Disorder
This trial is testing a new medication called SEP-363856 to see if it can help adults aged 18-65 with Generalized Anxiety Disorder. The medication is taken daily and aims to reduce anxiety symptoms.
Recruiting0 awards Phase 2 & 33 criteria
More about Lara Shirikjian, MD
Clinical Trial Related2 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Lara Shirikjian, MD has experience with
- Placebo
- SEP-4199 CR 200 Mg
- SEP-4199 CR 400 Mg
- SEP-363856
Breakdown of trials Lara Shirikjian, MD has run
Bipolar Depression
Anxiety Disorders
Generalized Anxiety Disorder
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lara Shirikjian, MD specialize in?
Lara Shirikjian, MD focuses on Bipolar Depression and Depression. In particular, much of their work with Bipolar Depression has involved treating patients, or patients who are undergoing treatment.
Is Lara Shirikjian, MD currently recruiting for clinical trials?
Yes, Lara Shirikjian, MD is currently recruiting for 2 clinical trials in Torrance California. If you're interested in participating, you should apply.
Are there any treatments that Lara Shirikjian, MD has studied deeply?
Yes, Lara Shirikjian, MD has studied treatments such as Placebo, SEP-4199 CR 200 mg, SEP-4199 CR 400 mg.
What is the best way to schedule an appointment with Lara Shirikjian, MD?
Apply for one of the trials that Lara Shirikjian, MD is conducting.
What is the office address of Lara Shirikjian, MD?
The office of Lara Shirikjian, MD is located at: Collaborative Neuroscience Research, LLC, Torrance, California 90502 United States. This is the address for their practice at the Collaborative Neuroscience Research, LLC.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.